| Literature DB >> 36104833 |
Polina Bikmulina1, Nastasia Kosheleva2,3,4, Anastasia Shpichka2,4, Vladimir Yusupov5, Vladimir Gogvadze6,7, Yury Rochev8, Peter Timashev2,4.
Abstract
SIGNIFICANCE: The method of photobiomodulation (PBM) has been used in medicine for a long time to promote anti-inflammation and pain-resolving processes in different organs and tissues. PBM triggers numerous cellular pathways including stimulation of the mitochondrial respiratory chain, alteration of the cytoskeleton, cell death prevention, increasing proliferative activity, and directing cell differentiation. The most effective wavelengths for PBM are found within the optical window (750 to 1100 nm), in which light can permeate tissues and other water-containing structures to depths of up to a few cm. PBM already finds its applications in the developing fields of tissue engineering and regenerative medicine. However, the diversity of three-dimensional (3D) systems, irradiation sources, and protocols intricate the PBM applications. AIM: We aim to discuss the PBM and 3D tissue engineered constructs to define the fields of interest for PBM applications in tissue engineering. APPROACH: First, we provide a brief overview of PBM and the timeline of its development. Then, we discuss the optical properties of 3D cultivation systems and important points of light dosimetry. Finally, we analyze the cellular pathways induced by PBM and outcomes observed in various 3D tissue-engineered constructs: hydrogels, scaffolds, spheroids, cell sheets, bioprinted structures, and organoids.Entities:
Keywords: low-level light; photobiomodulation; regenerative medicine; tissue engineering
Mesh:
Substances:
Year: 2022 PMID: 36104833 PMCID: PMC9473299 DOI: 10.1117/1.JBO.27.9.090901
Source DB: PubMed Journal: J Biomed Opt ISSN: 1083-3668 Impact factor: 3.758
Completed clinical trials on PBM.
| Number | Number of patients | Condition/disease | Results |
|---|---|---|---|
| NCT02383472 | 53 | Mild traumatic brain injury | Positive effects on verbal and visual memory, decreased reaction time, increased visual motor speed |
| NCT01439724 | 94 | Oral mucositis on the background of chemotherapy | Decreased morbidity, prevention of the oral mucositis relapses |
| NCT02267850 | 29 | Orthodontic treatment time | Accelerated tooth movement |
| NCT02181400 | 21 | Diabetic macular oedema | Anatomical improvement of macular oedema |
| NCT03741062 | 11 | Wound healing of human palatal tissue | Improved wound healing and postoperative comfort, prevention of scars, decreased consumption of analgesic pills |
| NCT00929773 | 100 | Chronic pain in neck and shoulders | Increased range of motion, decreased reported degree of pain |
| NCT01821352 | 53 | Obesity | Reduction of circumference of hips, waist, and upper abdomen |
| NCT02588599 | 54 | Toenail onychomycosis | Increased extent of clear nail |
| NCT01538199 | 28 | Major depressive disorder | Reduced posttreatment depression ratings |
Fig. 1Average diffusion distances of oxygen and nutrients (glucose) matched with cell viability on different depths of the scaffold and PBM penetration abilities. The diffusion distance for oxygen is , for glucose is . In a range of 0 to of scaffold cells are metabolically active and viable. After reaching diffusion limits, cells are exposed to deprivation of oxygen and nutrients. As a result, proliferation, metabolic activity, and general viability decrease. At depths more than 1 mm cell death occurs. Depending on tissue/scaffold and light source type, PBM penetration depth varies from 2 to 3 to 23 cm.
Fig. 2(a) the scheme of light transmittance in 3D scaffold systems. Dotted arrows indicate scattering, absorption, and reflection of light. (b) The intersection of water absorption spectrum with the PBM therapeutic wavelengths range. The optical window, where the light absorbance is minimal, is between 600 and 1300 nm. The most spread and effective wavelengths of PBM are in the range of 600 and 1000 nm.
Fig. 3Primary events in cells induced by red and NIR light. First, light is absorbed by CCO (unit IV) and as a result, an inhibitory molecule of NO is released. NO can promote endothelial cell differentiation and regulate various enzymes. Moreover, the activity of CCO increases and the transport of electrons within the respiratory chain is stimulated. As a result, more the leakage of electrons increases and oxygen molecules () are converted into superoxide radical (). Reactive oxygen species can facilitate release of mitochondrial into cytosol. All of these factors, NO, reactive oxygen species, ATP, and , can act together or individually as mediators of cellular pathways and lead to activation of proliferation, cell differentiation, protection of oxidative cell damage, and modulation of apoptosis.
Parameters and effects of PBM in scaffolds.
| Cell type | Scaffold | Source type | Wavelength (nm) | Energy density (fluence) ( | Power density ( | Cultivation after treatment | Result | Ref. |
|---|---|---|---|---|---|---|---|---|
| DPSC | Pluronic® F-127 hydrogel incorporated with BMP4 | Laser | 660 | 3 or 5 | 710 | 21 days in culture 8 weeks in animals | Increased cell proliferation, acceleration of odonto/osteogenic differentiation |
|
| Primary gingival fibroblasts | Collagen matrix | LED | 780 | 0.5; 1.5; 3 | 25 | 6 days in culture | Enhanced gene expression of hCOL-I and hEGF and increased cell viability |
|
| Vero (epithelial cell line) | Porcine serous collagen | LED | 630 | 30 | 24.1 | 7 days in culture | Increased ECM deposition and proliferation |
|
| BM-MSC | Bio-Oss (deproteinized bovine bone) | Laser | 810 | 4 | 200 | 3 weeks in animals | New bone formation |
|
| MSC | Coralline biomatrices | Laser | 633 | — | 0.5 mW | 1 to 7, 10, 14, 21, 28 days, culture | Osteogenic differentiation higher ossification levels |
|
| ADSC | Acellular dermal matrix | Laser | 633 | 1 | — | 14, 28, 56 days in animals | Increased viability and proliferation, bone regeneration |
|
| NSC | GelMA/PEGDA | LED | 635 | — | 10.95 | 14 days culture | Neuronal differentiation and suppressed glial differentiation |
|
| Embryonic NSC | NVR‐gel (cross‐linked hyaluronic acid enriched with laminin, BDNF and IGF-1) | Laser | 780 | — | 20 to 500 | 24 days in culture | Increased neuronal sprouting |
|
| DPSC | Mg-based, Zn-doped bioceramic scaffolds | Laser | 660 | 2 or 4, every 3 days | — | 28 days culture | Increase of odontogenesis-related markers, newly formed Ca-P tissue was formed |
|
| HUVEC and ADSC coculture | Fibrin gel | LED | 632 | 24 | 12 | 7 days in culture | Promoted vascularization |
|
| L929 and NIH3T3 | Fucoidan/alginate-polyethylene glycol-gellan gum 27 (Fu/AL-PEG@GGH) hydrogel | Laser | 635 | 4 | 417 | 1, 2, or 3 days culture | Increased cell migration, cell viability, collagen deposition |
|
| BM-MSC | Silk scaffolds | Polychromatic plasma arc lamp | 590, 633, 666, 712, 812, 1018, 1128, 1356, 1395 | — | 130 | 7, 14, or 28 days | Osteogenic differentiation, mineral deposition, F-actin reorganization |
|
| ADSC | Poly-lactic-co-glycolic acid (PLGA) scaffold | Laser | 660 | 13.3 | 24,62 | 16 weeks in animals | New bone formation, osteogenic differentiation |
|
| MC3T3 (osteoblastic cell line) | Glass-ceramic scaffold (biosilicate) | Laser | 830 | 10 | — | 7 days in culture | Increased proliferation |
|
| BM-MSC | Type I collagen scaffold | Laser | 810 | 4; every other day | 430 | 3 weeks in animals | Bone formation |
|
| DPSC | Agarose gel | Laser | 660 | 3.3; every 6 h | — | 7 and 14 days, culture | More effective osteogenic, chondrogenic, or adipogenic differentiation |
|
ADSC, adipose-derived stem cells; BM-MSC, bone marrow MSC; DPSC, dental pulp stem cells; MSC, mesenchymal stromal cells; NSC, neural stem cells; HUVEC, human umbilical vein endothelial cells
Fig. 4The possibilities of PBM to stimulate various aspects of cell physiology in 3D tissue engineered constructs (scaffolds or hydrogels) during the bioprinting, cultivation, differentiation, and transplantation.